#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Angiosarcoma metastatic Scedosporium infection Fusarium infection Von Hippel-Lindau disease Partial lipodystrophy Gaucher's disease type I Congenital leptin deficiency Krabbe's disease Metachromatic leukodystrophy Oesophageal squamous cell carcinoma stage II Ependymoma Pulmonary hypertension Myelodysplastic syndrome with excess blasts Congenital megacolon Amyotrophic lateral sclerosis gene carrier More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia SAPHO syndrome – Diagnostics Vascular malformation – Life with Disease Progressive supranuclear palsy Medulloblastoma – Treatment Niemann-Pick disease – Trials in Disease Mantle cell lymphoma – Treatment Hereditary neuropathic amyloidosis – Trials in Disease Alagille syndrome – Basic Information Ewing’s sarcoma recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ale.c04 Macitentan Gns561 Imgn151 Efepoetin Alfa Durvalumab Omp65 Ertugliflozin Suxamethonium Chloride Calcium Chloride Hexahydrate Benzathine Benzylpenicillin Mesenchymal Cells Immunoglobulin G AZD0022 Cetirizine Collagenase RO7268489 Glucose Monohydrate Ph. Eur. Vorasidenib Quercetin More therapies…

    Learn about Your Condition

    Normal pressure hydrocephalus Intracranial aneurysm COVID-19 External cephalic version Sarcoidosis EGFR gene mutation Pulmonary embolism Type IIa hyperlipidaemia Hepatitis alcoholic HER2 positive breast cancer Ewing's sarcoma recurrent Hepatobiliary disease Anal fistula Organ donor BRAF gene mutation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Renal transplant

  • Study of immunosuppression reduction in kidney transplant patients with septic shock or respiratory failure receiving drug combination therapy in intensive care

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Ciclosporin
    • Mycophenolic Acid
    • Azathioprine
    France

  • Study on Preventing CMV Infection in Low-Risk Kidney Transplant Patients Using Ganciclovir and Valganciclovir

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ganciclovir
    • Valganciclovir Hydrochloride
    Spain

  • Study of Belatacept versus Tacrolimus in Kidney Transplant Recipients with Subclinical Antibody Mediated Rejection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Belatacept
    • Tacrolimus
    France

  • Study on the Safety and Effectiveness of Dapagliflozin for Kidney Function in Non-Diabetic Kidney Transplant Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Dapagliflozin
    Denmark

  • Study of Ravulizumab to Prevent Delayed Graft Function in Adult Patients After Kidney Transplant

    Recruiting

    3 1 1
    Investigated Diseases:
    • Delayed graft function
    • Renal transplant
    Investigated Drugs:
    • Ravulizumab
    Austria Czechia France Germany Italy Poland +2

  • Comparison of Tacrolimus alone versus Tacrolimus, Mycophenolate mofetil and Prednisone combination in elderly kidney transplant patients to reduce infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Mycophenolate Mofetil
    • Prednisone
    • Tacrolimus
    The Netherlands
1 2 3 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!